Corcept Therapeutics Incorporated Stock In The News
| CORT Stock | USD 22.80 0.59 2.66% |
The overall news coverage of Corcept Therapeutics Incorporated from major news outlets shows bullish sentiment on 14 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Corcept Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Corcept Therapeutics Incorporated. The specific impact of Corcept Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Corcept Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Corcept Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Corcept Therapeutics Backtesting and Corcept Therapeutics Hype Analysis.
Corcept |
Corcept Therapeutics Today Top News and Investor Outlook
Corcept Therapeutics Incorporated Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Corcept and other traded companies coverage. We help investors stay connected with Corcept headlines for the 29th of April to make an informed investment decision based on correlating the impacts of news items on Corcept Stock performance. Please note that trading solely based on the Corcept Therapeutics Incorporated hype is not for everyone as timely availability and quick action are needed to avoid losses.Corcept Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Corcept earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Corcept Therapeutics that are available to investors today. That information is available publicly through Corcept media outlets and privately through word of mouth or via Corcept internal channels. However, regardless of the origin, that massive amount of Corcept data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Corcept Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Corcept Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Corcept Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Corcept Therapeutics alpha.
Corcept Largest EPS Surprises
Earnings surprises can significantly impact Corcept Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-05-01 | 2017-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2016-11-01 | 2016-09-30 | 0.01 | 0.02 | 0.01 | 100 | ||
2015-11-05 | 2015-09-30 | -0.02 | -0.01 | 0.01 | 50 | ||
2015-05-07 | 2015-03-31 | -0.04 | -0.05 | -0.01 | 25 | ||
2014-11-04 | 2014-09-30 | -0.07 | -0.06 | 0.01 | 14 | ||
2014-03-05 | 2013-12-31 | -0.1 | -0.11 | -0.01 | 10 |
Corcept Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Corcept Therapeutics Stock. Current markets are strongly bullish. About 73% of major world exchanges and indexes are currently up. See today's market update for more information.
25th of April 2024
Levi Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated an Upcoming... at accesswire.com
22nd of April 2024
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial ... at finance.yahoo.com
17th of April 2024
Corcept Upgraded to Strong Buy Heres What You Should Know at zacks.com
16th of April 2024
Levi Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated an Upcoming... at accesswire.com
15th of April 2024
Corcept wraps up Phase 2 ALS drug trial enrollment at investing.com
11th of April 2024
Upcoming Deadline to Share in Corcept Therapeutics Incorporated Class Action Settlement - ... at news.google.com
9th of April 2024
Corcept Completes Enrollment in Ovarian Cancer Study at zacks.com
4th of April 2024
Disposition of 5443 shares by Joseph Lyon of Corcept Therapeutics at 26.0011 subject to Ru... at MacroaxisInsider
1st of April 2024
Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Ad... at finance.yahoo.com
8th of February 2024
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Prov... at finance.yahoo.com
Corcept Therapeutics Investors Sentiment
The influence of Corcept Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Corcept. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Corcept Therapeutics' public news can be used to forecast risks associated with an investment in Corcept. The trend in average sentiment can be used to explain how an investor holding Corcept can time the market purely based on public headlines and social activities around Corcept Therapeutics Incorporated. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Corcept Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Corcept Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Corcept Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Corcept Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Corcept Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Corcept Therapeutics' short interest history, or implied volatility extrapolated from Corcept Therapeutics options trading.
Check out Corcept Therapeutics Backtesting and Corcept Therapeutics Hype Analysis. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Corcept Stock analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Corcept Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corcept Therapeutics. If investors know Corcept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corcept Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.995 | Earnings Share 0.94 | Revenue Per Share 4.658 | Quarterly Revenue Growth 0.314 | Return On Assets 0.1113 |
The market value of Corcept Therapeutics is measured differently than its book value, which is the value of Corcept that is recorded on the company's balance sheet. Investors also form their own opinion of Corcept Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Corcept Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corcept Therapeutics' market value can be influenced by many factors that don't directly affect Corcept Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corcept Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corcept Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corcept Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.